Dasatinib (Sprycel) - adult acute lymphocytic leukemia (Ph(+) ALL)
1. Can anyone provide information about the experiences of adult acute lymphocytic leukemia (Ph(+) ALL) patients who stopped taking Dasatinib (Sprycel) after going into remission and completing consolidation therapy? A stem cell transplantation was not and will not be performed.
2. What information and/or research is there on continuing on Dasatinib (Sprycel) after Philadelphia chromosome positive adult acute lymphocytic leukemia (Ph(+) ALL) patients go into remission and complete consolidation therapy to help keep the leukemia from coming back? A stem cell transplantation was not and will not be performed.
Thank you
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards